APA (7th ed.) Citation

Xin, Y., Cao, F., Yang, H., Zhang, X., Chen, Y., Cao, X., . . . Zhou, J. (2022, August). Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. Frontiers in Immunology.

Chicago Style (17th ed.) Citation

Xin, Yujing, Fei Cao, Hongcai Yang, Xinyuan Zhang, Yi Chen, Xiaojing Cao, Xiang Zhou, Xiao Li, and Jinxue Zhou. "Efficacy and Safety of Atezolizumab Plus Bevacizumab Combined with Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma." Frontiers in Immunology Aug. 2022.

MLA (9th ed.) Citation

Xin, Yujing, et al. "Efficacy and Safety of Atezolizumab Plus Bevacizumab Combined with Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma." Frontiers in Immunology, Aug. 2022.